Mock James M
Chief Financial Officer at MRNA; Please See Remarks at RVTY
- Sold, on record
- $8.3M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Sep 10, 2026
- Form 144 notices
- 12
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MRNARoutineAug 28, 2024 2024
Sold 1,321 shares at $79.39 ($105k)
Mock James M, Chief Financial Officer
10b5-1 planSold 13.3% of holdings ($788k position)8,600 shares left1.9x usual sizeFollows a Form 144Filing
- 2 Form 144 notice MRNANoticeAug 29, 2024 +1 day
Filed to sell 162 shares ($13k)
Mock James M, Officer
No 10b5-1 plan0.2x usual sizeFiling
- 3 Form 4 sale MRNARoutineAug 29, 2024 same day
Sold 162 shares at $78.03 ($13k)
Mock James M, Chief Financial Officer
10b5-1 planSold 1.8% of holdings ($697k position)8,767 shares left0.2x usual sizeFollows a Form 144Filing
- 4 Form 144 notice MRNANoticeOct 7, 2024 +39 days
Filed to sell 715 shares ($43k)
Mock James M, Officer
No 10b5-1 plan1x usual sizeFiling
- 5 Form 4 sale MRNARoutineOct 7, 2024 same day
Sold 715 shares at $60.12 ($43k)
Mock James M, Chief Financial Officer
10b5-1 planSold 7% of holdings ($614k position)9,505 shares left1x usual sizeFollows a Form 144Filing
- 6 Form 144 notice MRNANoticeNov 29, 2024 +53 days
Filed to sell 1,420 shares ($61k)
Mock James M, Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale MRNARoutineNov 29, 2024 same day
Sold 1,420 shares at $42.79 ($61k)
Mock James M, Chief Financial Officer
10b5-1 planSold 11.4% of holdings ($534k position)11,066 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 4 sale MRNARoutineSep 10, 2026 +650 days
Sold 34,836 shares at $134.49 ($4.7M)
Mock James M, Chief Financial Officer
10b5-1 planSold 37% of holdings ($12.7M position)59,375 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Sep 14, 2026 | MRNA | Chief Financial Officer | Form 4 sale | 34,836 | $4.7M | 37.0% | Routine | SEC |
| Nov 29, 2024 | Dec 2, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 1,420 | $61k | 11.4% | Routine | SEC |
| Nov 29, 2024 | Nov 29, 2024 | MRNA | Officer | Form 144 notice | 1,420 | $61k | Notice | SEC | |
| Oct 7, 2024 | Oct 8, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 715 | $43k | 7.0% | Routine | SEC |
| Oct 7, 2024 | Oct 7, 2024 | MRNA | Officer | Form 144 notice | 715 | $43k | Notice | SEC | |
| Aug 29, 2024 | Aug 30, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 162 | $13k | 1.8% | Routine | SEC |
| Aug 29, 2024 | Aug 29, 2024 | MRNA | Officer | Form 144 notice | 162 | $13k | Notice | SEC | |
| Aug 28, 2024 | Aug 29, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 1,321 | $105k | 13.3% | Routine | SEC |
| Aug 28, 2024 | Aug 28, 2024 | MRNA | Officer | Form 144 notice | 1,321 | $105k | Notice | SEC | |
| Jul 8, 2024 | Jul 9, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 689 | $81k | 8.7% | Routine | SEC |
| Jul 8, 2024 | Jul 8, 2024 | MRNA | Officer | Form 144 notice | 689 | $81k | Notice | SEC | |
| Jun 3, 2024 | Jun 4, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 691 | $97k | 9.6% | Routine | SEC |
| Jun 3, 2024 | Jun 3, 2024 | MRNA | Officer | Form 144 notice | 691 | $97k | Notice | SEC | |
| May 29, 2024 | May 30, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 183 | $26k | 3.0% | Routine | SEC |
| May 29, 2024 | May 29, 2024 | MRNA | Officer | Form 144 notice | 183 | $26k | Notice | SEC | |
| May 28, 2024 | May 29, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 648 | $105k | 10.2% | Routine | SEC |
| May 28, 2024 | May 28, 2024 | MRNA | Officer | Form 144 notice | 648 | $105k | Notice | SEC | |
| Apr 8, 2024 | Apr 9, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 705 | $72k | 12.3% | Routine | SEC |
| Apr 8, 2024 | Apr 8, 2024 | MRNA | Officer | Form 144 notice | 705 | $72k | Notice | SEC | |
| Feb 29, 2024 | Mar 1, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 647 | $61k | 13.1% | Routine | SEC |
| Feb 29, 2024 | Feb 29, 2024 | MRNA | Officer | Form 144 notice | 647 | $61k | Notice | SEC | |
| Jan 8, 2024 | Jan 9, 2024 | MRNA | Chief Financial Officer | Form 4 sale | 772 | $85k | 17.5% | Routine | SEC |
| Jan 8, 2024 | Jan 8, 2024 | MRNA | Officer | Form 144 notice | 772 | $85k | Notice | SEC | |
| Oct 6, 2023 | Oct 10, 2023 | MRNA | Chief Financial Officer | Form 4 sale | 2,858 | $293k | 49.2% | Routine | SEC |
| Oct 6, 2023 | Oct 6, 2023 | MRNA | Officer | Form 144 notice | 2,858 | $293k | Notice | SEC | |
| Jun 24, 2022 | Jun 27, 2022 | RVTY | Please See Remarks | Form 4 sale | 5,025 | $731k | 15.4% | Plan not stated | SEC |
| Sep 20, 2021 | Sep 21, 2021 | RVTY | Please See Remarks | Form 4 sale | 6,080 | $1.1M | 20.7% | Plan not stated | SEC |
| Oct 2, 2020 | Oct 5, 2020 | RVTY | Please See Remarks | Form 4 sale | 5,623 | $700k | 17.1% | Plan not stated | SEC |